FOXO4-DRI Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous (extrapolated from IP injection in mice) Frequency: Every 3 days for treatment course (mouse protocol extrapolation) Dose Range: No established human dose. Mouse studies used 5 mg/kg IP every 3 days for 3 weeks. Cycle Length: 3 weeks (mouse protocol); human protocols not established
Storage
Lyophilized: -20 °C (-4 °F) Reconstituted: 2-8 °C (35.6-46.4 °F) Shelf Life: 14 days
Safety & Contraindications
Safety: No human safety data exists Mouse studies used doses of 5 mg/kg via intraperitoneal injection Transient weight loss and reduced food intake observed in treated mice
Contraindications: Not established — no human data; Active wound healing (senescent cells play roles in repair); Pregnancy and breastfeeding